💫🌟Early-Onset Cancers: Unraveling Biological Causes and Clinical Implications🌟💫 @OncoAlert 🔷 Understanding Early-Onset Cancers Over the past three decades, the incidence of early-onset (EO) cancers—those diagnosed in individuals under the age of 50—has been rapidly rising. While EO cancers traditionally affected older adults, recent epidemiological data highlight a disturbing increase in diagnoses among adolescents and young adults, notably in cancers like colorectal cancer (CRC) and breast cancer (BC). 🔷 Key Points • Rising Incidence: ➤ The incidence of EO cancers globally increased by 80% from 1990 to 2019, especially in gastrointestinal, colorectal, and breast cancers. ➤ Notably, EO-CRC is projected to account for one-third of all CRC cases by 2030. • Impact of the Exposome: ➤ The rise in EO cancers may be linked to changes in environmental exposures, including diet Westernization, increased consumption of processed foods, exposure to carcinogens, and shifts in lifestyle factors like physical inactivity and obesity. ➤ Environmental pollutants, such as PM2.5 and microplastics, are also suspected contributors. • Challenges in Screening: ➤ Current screening protocols may not be well-suited to EO cancers, especially in CRC, where tumors may develop faster in younger populations. ➤ Innovations like circulating tumor DNA (ctDNA) monitoring could be key in developing more effective, non-invasive screening strategies for early detection. 🔷 Hypotheses on EO Cancer Evolution • Biological Peculiarities: ➤ EO cancers may follow different biological pathways compared to late-onset cancers. There is growing interest in understanding if EO tumors exhibit distinct molecular profiles that affect treatment responses, potentially requiring tailored therapeutic approaches. • Multi-Omics Integration: ➤ Comprehensive multi-omics profiling is essential to uncover the genetic, epigenetic, and transcriptomic features unique to EO cancers. International collaborations and biobanks focusing on EO cancer samples are critical to advancing this research. 🔷 Conclusion The surge in early-onset cancers presents an urgent public health challenge. By integrating epidemiological, environmental, and molecular data, we can develop a deeper understanding of the biology driving these cancers. This approach, referred to as the EO-cancer integrome, could ultimately lead to more effective prevention, diagnosis, and treatment strategies. #EarlyOnsetCancer #CancerResearch #Oncology #PrecisionMedicine #ColorectalCancer #BreastCancer #Exposome #PublicHealth #MultiOmics cell.com/cell-reports-medici…